Pseudopseudohypoparathyroidism

Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's weight loss doctor NYC
Philadelphia GLP-1 weight loss and GLP-1 clinic NYC
| Pseudopseudohypoparathyroidism | |
|---|---|
| |
| Synonyms | |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Short stature, round face, subcutaneous ossifications |
| Complications | |
| Onset | |
| Duration | |
| Types | |
| Causes | Genetic mutation in the GNAS complex locus |
| Risks | |
| Diagnosis | Clinical evaluation, genetic testing |
| Differential diagnosis | Pseudohypoparathyroidism, Albright's hereditary osteodystrophy |
| Prevention | |
| Treatment | Symptomatic management |
| Medication | |
| Prognosis | Generally good |
| Frequency | Rare |
| Deaths | |
Pseudopseudohypoparathyroidism (PPHP) is a rare inherited disorder, closely related to Albright's hereditary osteodystrophy (AHO). It is characterized by physical features that resemble those seen in hypoparathyroidism, but without the biochemical abnormalities associated with it.
Signs and Symptoms[edit]
Patients with PPHP typically exhibit features of AHO, such as short stature, obesity, round face, subcutaneous calcifications, and brachydactyly. However, they do not show the resistance to parathyroid hormone seen in pseudohypoparathyroidism (PHP).
Genetics[edit]
PPHP is caused by mutations in the GNAS1 gene, which encodes the alpha subunit of the stimulatory G protein. This protein plays a crucial role in the regulation of cellular responses to hormones. The mutations in PPHP are inherited in an autosomal dominant manner, meaning one copy of the altered gene in each cell is sufficient to cause the disorder.
Diagnosis[edit]
The diagnosis of PPHP is based on clinical features and genetic testing. The presence of AHO features without biochemical evidence of hypoparathyroidism is suggestive of PPHP. Genetic testing can confirm the diagnosis by identifying a mutation in the GNAS1 gene.
Treatment[edit]
There is no specific treatment for PPHP. Management is symptomatic and supportive, focusing on controlling the symptoms and improving the quality of life. This may include physiotherapy for mobility issues, and psychological support for any associated mental health issues.
See Also[edit]
References[edit]
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
